Evaluation of serum interleukin-17 A and interleukin-22 levels in pediatric patients with autism spectrum disorder: a pilot study

Dina E. Sallam,Youstina S. Shaker,Gehan A. Mostafa,Reham M. El-Hossiny,Sara I. Taha,Mostafa Abd Elazeem Hassan Ahamed
DOI: https://doi.org/10.1186/s12887-023-04484-2
2024-01-07
BMC Pediatrics
Abstract:Many neurodevelopmental abnormalities are connected to autism spectrum disorder (ASD), which can result in inflammation and elevated cytokine levels due to immune system dysregulation. Interleukin (IL)-17 A and IL-22 have been linked to the regulation of host defense against pathogens at the barrier surface, the regeneration of injured tissue, and the integration of the neurological, endocrine, and immune systems. Several studies have investigated the possible connection between IL-17 A and ASD as well as the severity of behavioral symptoms, but few of them included IL-22.
pediatrics
What problem does this paper attempt to address?